Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Sun Pharmaceutical Industries, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Sun Pharmaceutical Industries, Inc.

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Sun Pharmaceutical Industries, Inc.. It includes 1 original PMA approval. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 3, 1999 to Nov 2, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MVF appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P990019, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 29 Dunham Rd., Billerica, MA, 01821. Recorded on P990019/S010, decision dated Nov 2, 2026.

Changes described in PMA records

P990019/S010: BLU-U Blue Light Photodynamic Therapy Illuminator (Model 4170E)

The FDA recorded an approval decision on 2026-11-02 for P990019/S010, a supplement to the BLU-U® Blue Light Photodynamic Therapy Illuminator (Model 4170E) held by Sun Pharmaceutical Industries, Inc. The device falls under the photodynamic therapy laser system category, with product code MVF and a listed specialty of general and plastic surgery.

The supplement is recorded as a real-time process submission with the stated reason of change to design, components, specifications or material. Its recorded scope is software changes adding error remediation approaches and optimization of software intercommunications. This decision covers that supplement only, not a new approval of the underlying system. The source lists no supporting documents, so the specific software versions, affected components and review basis remain unknown.

FDA approval-order wording

approval for software changes adding error remediation approaches and optimization of software intercommunications.

Nov 2, 2026 · Real-Time Process

P990019: BLU -U BLUE LIGHT PHOTODYNAMIC THERAPY ILLUMINATOR

FDA’s recorded scope: The devices is indicated for use in Photodynamic Therapy with Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp.

Dec 3, 1999

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Sun Pharmaceutical Industries, Inc.PMA supplementNov 2, 2026FDA
Sun Pharmaceutical Industries, Inc.PMA approvalDec 3, 1999FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.